Clinical Oncology Dosing Essentials

Test

Jugadas 12 %Acierto 75 Tiempo medio 00:-1

Crear copia

Sobre esta actividad

Oncology dosing and decision points

Creada por

Dr.Samah Mahmoud

Egipto

Descarga la versión para jugar en papel

Top 10 resultados

Todavía no hay resultados para este juego. ¡Sé el primero en aparecer en el ranking! Inicia sesión para identificarte.

Crea tu propio juego gratis desde nuestro creador de juegos

Compite contra tus amigos para ver quien consigue la mejor puntuación en esta actividad

Crear reto

		%
	Anónimo	%
		%
		%

Imprime tu juego

Clinical Oncology Dosing Essentials


Clinical Oncology Dosing EssentialsVersión en línea Oncology dosing and decision points por Dr.Samah Mahmoud 1 What is the IV trastuzumab loading dose for a standard regimen? a 4 mg/kg b 6 mg/kg c 8 mg/kg every week d 8 mg/kg 2 Which trastuzumab formulation uses a fixed dose regardless of body weight? a SC formulation b Oral formulation c IV formulation with loading dose d IV maintenance dose only 3 True or False: For SC trastuzumab, actual body weight is used to determine the dose. a Only if converting from IV b Only for very high BMI c True d False 4 A patient receiving trastuzumab IV has a weight-based calculation. Which factor is most important to confirm before dose verification? a Patient age b Race of the patient c Formulation (IV vs SC) d Allergies to penicillin 5 Case: A 52-year-old woman weighing 95 kg needs trastuzumab. Which statement is correct? a Trastuzumab IV maintenance dose = 8 mg/kg b Trastuzumab SC dose = 600 mg regardless of weight c Trastuzumab SC dose = 760 mg d Trastuzumab IV loading dose = 600 mg 6 True or False: The fixed 600 mg SC dose of trastuzumab was chosen to achieve exposure similar to standard IV dosing. a False b Only for average-weight patients c False unless weight > 100 kg d True 7 Case: You need to decide dosing for a patient with obesity undergoing curative therapy. What is a critical consideration stated in the material? a Always reduce dose by 50% in obesity b Obesity requires switching to SC formulation immediately c Obesity mandates a 20% dose increase d Obesity alone is not a reason for dose reduction 8 Short Answer: What is the general rule for verifying chemotherapy dose calculations before administration? a Dose verification is optional b Always verify the raw patient data before trusting the calculated dose c Verify after administration d Verify only for weight-based dosing Feedback 1 IV trastuzumab uses an 8 mg/kg loading dose (followed by 6 mg/kg every 3 weeks). This is shown in the dosing table for trastuzumab IV formulations. 2 The SC (subcutaneous) formulation uses a fixed 600 mg dose q3 weeks, independent of weight, per the presented notes. 3 SC trastuzumab uses a fixed 600 mg dose regardless of body weight. 4 Always verify whether the formulation is IV or SC since dosing depends on formulation, not just weight. 5 SC dose is fixed at 600 mg; IV loading is 8 mg/kg and maintenance is 6 mg/kg q3w. 6 The fixed 600 mg SC dose was modeled to approximate exposure of IV dosing across weights. 7 The material notes that obesity alone does not justify dose reduction in curative settings. 8 The quick quiz emphasizes not trusting the calculated dose until raw data is confirmed.

Puedes integrar el juego en un LMS compatible con LTI 1.1 o LTI 1.3 como Canvas, Moodle, o Blackboard. De esta manera podrás guardar las puntuaciones automáticamente en el libro de calificaciones de esa plataforma.

Clinical Oncology Dosing Essentials

Test

Sobre esta actividad

Creada por

Descarga la versión para jugar en papel

Top juegos

Test

Brawl stars preguntas

Test

Cultura general española

Test

Tipos de sintagmas (II)

Test

Verbos irregulares en Inglés

Test

cuanto sabes de Futbol

Clinical Oncology Dosing EssentialsVersión en línea

por Dr.Samah Mahmoud

What is the IV trastuzumab loading dose for a standard regimen?

Which trastuzumab formulation uses a fixed dose regardless of body weight?

True or False: For SC trastuzumab, actual body weight is used to determine the dose.

A patient receiving trastuzumab IV has a weight-based calculation. Which factor is most important to confirm before dose verification?

Case: A 52-year-old woman weighing 95 kg needs trastuzumab. Which statement is correct?

True or False: The fixed 600 mg SC dose of trastuzumab was chosen to achieve exposure similar to standard IV dosing.

Case: You need to decide dosing for a patient with obesity undergoing curative therapy. What is a critical consideration stated in the material?

Short Answer: What is the general rule for verifying chemotherapy dose calculations before administration?

Feedback